Research

October 28, 2021

Pancreatic beta-cell booster

Blocking inflammatory signaling improves beta-cell characteristics in a mouse model of type 2 diabetes and may provide added benefits to GLP-1R diabetes medications.

October 28, 2021

The challenge of rejection

Minimizing variation in how rejection is diagnosed and creating standardized surveillance protocols may help inform best practices in pediatric heart transplants.

October 28, 2021

VUMC researchers a step closer to broad ebolavirus protection

Seth Zost, PhD, has been honored for his research on COVID-19 and other life-threatening viral diseases.
October 28, 2021

Zost honored for research on COVID-19, other life-threatening viral diseases

Vanderbilt’s Seth Zost, PhD, has been awarded a major international prize for his research on COVID-19 and other life-threatening viral diseases. 

October 21, 2021

Study links genetic variants, protein expression and human diseases

An international research team has developed a new resource that connects genetic variants and protein expression, which is expected to speed the identification of genes that cause disease — and point to novel treatment strategies.

October 19, 2021

Artificial intelligence predicts opioid overdose in Tennessee

Researchers at Vanderbilt and the Tennessee Department of Health have developed 30-day predictive models for fatal and non-fatal opioid-related overdose among patients receiving opioid prescriptions in the state.